science
The First US Human CRISPR Trials Could Start Any Day Now

The first U.S. human trial using CRISPR to treat disease could kick off any day now. The trials, led by the University of Pennsylvania, will use the gene-editing tool to modify immune cells, prompting them to attack three different types of cancer. Read More >>

science
The FDA Just Approved Another Promising Immunotherapy For Cancer

On Wednesday—for only the second time—the American Food and Drug Administration approved a cutting-edge therapy that genetically modifies a patient’s blood cells in order to attack cancer. This time the therapy, known as CAR T-cell therapy, is designed to treat aggressive non-Hodgkin lymphoma. Read More >>

medicine
Biotech Firm Halts ‘Revolutionary’ Cancer Treatment After Patient Deaths

Following the deaths of five patients, Juno Therapeutics has decided to pull the plug on an experimental cancer treatment that boosts the power of a patient’s immune cells. The news comes just days after the company’s rival, Kite Pharma, announced its success with a similar method, showing there’s still hope for this potentially revolutionary gene therapy. Read More >>

medicine
New Cancer Therapy Leaves Three Dead

Clinical trials of a promising new therapy, in which white blood cells are reprogrammed to attack cancer cells, has resulted in the deaths of three patients. In response, the US Food and Drug Administration has ordered a temporary halt to the trial. Read More >>